Proteomic analysis of radioiodine-refractory differentiated thyroid cancer identifies CHI3L1 upregulation in association with dysfunction of the sodium-iodine symporter.

Li, Yunjie; Hu, Fengqiong; Deng, Jie; Huang, Xin; Zhou, Chunyan; Wu, Mengxue; Duan, Dong

Li, Yunjie; Hu, Fengqiong; Deng, Jie; Huang, Xin; Zhou, Chunyan; Wu, Mengxue; Duan, Dong.

Afiliación

Li Y; Department of Nuclear Medicine, The Second People's Hospital of Shenzhen, Shenzhen, Guangdong 518035, P.R. China.
Hu F; Department of Nuclear Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P.R. China.
Deng J; Department of Nuclear Medicine, The Second Affiliated Hospital of Army Medical University, Chongqing 400037, P.R. China.
Huang X; Department of Nuclear Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P.R. China.
Zhou C; Department of Nuclear Medicine, Chongqing General Hospital, Chongqing 401147, P.R. China.
Wu M; Department of Nuclear Medicine, The First Hospital Affiliated to Army Medical University, Chongqing 400038, P.R. China.
Duan D; Department of Nuclear Medicine, Chongqing General Hospital, Chongqing 401147, P.R. China.

Oncol Lett ; 25(1): 36, 2023 Jan.

Article en En | MEDLINE | ID: mdl-36589664

Palabras clave

chitinase-3-like 1; comparative proteomics; radioiodine-refractory thyroid cancer; sodium-iodine symporter; targeting therapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Oncol Lett Año: 2023 Tipo del documento: Article Pais de publicación: Grecia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google